DOCSLIB.ORG

Industrial Chemicals, Ashfords Dictionary, Chemical Name Index

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

2 Chemical name index A A ACA 4-AA ACA AA ACAC AA acamprosate calcium AAA acarbose AABA ACB AADMC 7-ACCA AAEM ACE AAMX acebutolol AAOA aceclidine AAOC aceclofenac AAOT acemetacin AAPP acenaphthene AAPT acenocoumarol 4-ABA acephate ABA acepromazine abacavir acequinocyl ABAH acesulfame-K abamectin acetaldehyde ABFA acetaldehyde ethyl phenethyl diacetal ABL acetaldehyde oxime ABPA acetaldehyde n-propyl phenethyl diacetal ABS acetaldoxime ABS acetal resins O-ABTF acetal resins P-ABTF acetamide ACN acetamidine hydrochloride 7-ACA 5-acetamido-2-aminobenzenesulfonic acid 7-ANCA 6-acetamido-2-aminophenol-4-sulfonic acid Name Index: Ashford’s Dictionary of Industrial Chemicals 3-acetamidoaniline 3-acetamidoaniline acetic acid, s-butyl ester 4-acetamidoaniline acetic acid, calcium salt p-acetamidoanisole acetic acid, chromium salt 4-acetamidobenzenesulfonyl chloride acetic acid, cinnamyl ester 2-acetamidocinnamic acid acetic acid, citronellyl ester 3-acetamido-2-hydroxyaniline-5-sulfonic acid acetic acid, cobalt salt 1-acetamido-7-hydroxynaphthalene acetic acid, decahydro-β-naphthyl ester 8-acetamido-1-hydroxynaphthalene-3,6-disulfonic acid acetic acid, dicyclopentenyl ester 1-acetamido-7-naphthol acetic acid, diethylene glycol monobutyl ether ester 4-acetamidonitrobenzene acetic acid, 2-ethoxyethyl ester p-acetamidophenol acetic acid, ethoxypropyl ester 3-acetamidopropylsulfonic acid, calcium salt acetic acid, ethyl diglycol ester 5-acetamido-2,4,6-triiodo-N-methylisophthalamic acid acetic acid, ethylene glycol diester 4-acetamido-2-ethoxybenzoic acid, methyl ester acetic acid, ethylene glycol monobutyl ether ester L-2-acetamido-3-mercaptopropionic acid acetic acid, ethyl ester 1-acetamido-8-naphthol-3,6-disulfonic acid acetic acid, 2-ethylhexyl ester acetaminophen acetic acid, eugenyl ester acetamiprid acetic acid, geraniol ester acetanilide acetic acid, glyceryl diester acet-p-anisidide acetic acid, glyceryl triester acetazolamide acetic acid, 2-hexenyl ester acetic acid acetic acid, 3-hexenyl ester acetic acid, aluminium salt acetic acid, hexyl ester acetic acid, aluminium salt, basic acetic acid, n-hexyl ester acetic acid, amyl ester acetic acid, isoamyl ester acetic acid, antimony salt acetic acid, isobornyl ester acetic acid, benzyl ester acetic acid, isobutyl ester acetic acid, bornyl ester acetic acid, isoheptyl ester acetic acid, n-butyl ester acetic acid, isononyl ester Name Index: Ashford’s Dictionary of Industrial Chemicals acetic acid, isopropenyl ester acetic acid, isopropenyl ester acetoacet-2,5-dimethoxy-4-chloroanilide acetic acid, isopropyl ester acetoacet-N,N-dimethylamide acetic acid, lead salt acetoacet-N-methylamide acetic acid, linalyl ester acetoacetamide acetic acid, lithium salt 5-acetoacetamidobenzimidazolone acetic acid, magnesium salt acetoacetanilide acetic acid, menthyl ester acetoacet-o-anisidide acetic acid, 4-methoxybenzyl ester acetoacet-p-anisidide acetic acid, 2-methoxyethyl ester acetoacet-o-chloroanilide acetic acid, methoxypropyl ester acetoacet-4-chloro-2,5-dimethoxyanilide acetic acid, methyl ester acetoacetic acid, t-butyl ester acetic acid, nickel salt acetoacetic acid, ethyl ester acetic acid, phenyl ester acetoacetic acid, isopropyl ester acetic acid, 1-phenylethyl ester acetoacetic acid, methyl ester acetic acid, 2-phenylethyl ester 2-(acetoacetoxyethyl) methacrylate acetic acid, potassium salt acetoacet-p-phenetidide acetic acid, propylene glycol monoethyl ether ester acetoacet-o-toluidide acetic acid, propylene glycol monomethyl ether ester acetoacet-p-toluidide acetic acid, n-propyl ester acetoacet-2,4-xylidide acetic acid, sodium salt α-acetobromo-D-glucose acetic acid, stearylammonium salt 3-acetobutyrolactone acetic acid, sucrose octaester acetochlor acetic acid, tallowammmonium salt acetodiphosphonic acid acetic acid, triethylene glycol diester acetoguanamine acetic acid, 3,5,5-trimethylhexyl ester acetohexamide acetic acid, zinc salt acetohydrazide acetic acid, zirconium salt acetohydroxamic acid acetic anhydride acetoin acetoacet-N,N-diethylamide acetol Name Index: Ashford’s Dictionary of Industrial Chemicals acetone acetone acetylacetone acetone cyanohydrin acetylacetone peroxide acetonedicarboxylic acid N-acetyl-p-aminoanisole acetonedicarboxylic acid, dimethyl ester N-acetyl-4-aminophenol acetone dimethyl acetal 3-acetylaniline acetone-diphenylamine condensates 4-acetylaniline acetonitrile p-acetylanisole acetonylacetone acetylated starch p-acetonylanisole acetylbenzene acetonylbenzene N-(p-acetylbenzenesulfonyl)-N'-cyclohexylurea acetophenetidine 4-acetylbiphenyl acetophenone acetylcedrene o-acetotoluene acetyl chloride p-acetotoluene acetylcholine chloride 4-acetoxyazetidin-2-one acetylcitric acid, tri-n-butyl ester 2-acetoxybenzoic acid acetylcitric acid, triethyl ester (3R,4R)-4-acetoxy-3-[(R)-1-(t-butyldimethylsilyloxy)- 4-acetyl-N-[(cyclohexylamino)carbonyl]benzenesulfon- ethyl]-2-azetidinone amide 21-acetoxy-11,17-dihydroxy-16α-methylpregna- acetylcyclopropane 1,4-diene-3,20-dione N-acetyl-L-cysteine 21-acetoxy-11,17-dihydroxy-16β-methylpregna- acetyl diethyl succinate 1,4-diene-3,20-dione 2-acetyl-10-(3-dimethylaminopropyl)phenothiazine 6-acetoxy-2,4-dimethyl-1,3-dioxane 4-acetyl-1,1-dimethyl-6-t-butylindane N-(2-acetoxyethyl)-N-(2-cyanoethyl)aniline acetylene 2-(2-acetoxyethyl)-6,6-dimethylnorpin-2-ene acetylene black 3-(4-acetoxy-3-methoxyphenyl)propene acetylenedicarboxylic acid 3-acetoxy-16-methylpregna-5,16-dien-20-one acetylene tetrabromide 3-acetoxypregna-5,16-dien-20-one acetylene urea 3α-acetoxypregn-16-ene-11,20-dione N-acetylethanolamine Name Index: Ashford’s Dictionary of Industrial Chemicals acetyl-gamma acid acetyl-gamma acid N-acetylthiazolidine-4-carboxylic acid N-acetylglucosamine 2-acetylthiophene N-acetyl-H acid N-acetyl-o-toluidine 6-acetyl-1,1,2,3,3,5-hexamethylindane acetyl tri-n-butyl citrate 6-acetyl-1,1,2,4,4,7-hexamethyltetralin acetyl triethyl citrate acetyl hydrazine 4-acetyl-1,1,6-trimethylethanooctahydronaphthalene 1-acetyl-4-(4'-hydroxyphenyl)piperazine ACH 1-acetyl-2-imidazolidinone ACHN acetyl-J acid acibenzolar-S-methyl N-acetyl-D-mannosamine aciclovir 2-acetyl-6-methoxynaphthalene 1,2,4-acid N-acetyl-5-methoxytryptamine 2,4,8-acid acetylmethylcarbinol Acid Black 1 2-acetylnaphthalene Acid Black 2 N-acetylneuraminic acid Acid Black 24 m-acetylphenol Acid Black 26 o-acetylphenol Acid Black 28 N-acetyl-m-phenylenediamine Acid Black 52 N-acetyl-p-phenylenediamine Acid Black 58 N-acetylpiperazine Acid Black 60 acetyl propionyl Acid Black 63 2-acetylpyrazine Acid Black 84 2-acetylpyridine Acid Black 107 2-acetylresorcinol Acid Black 172 N-acetylsalicylamide Acid Black 180 acetylsalicylic acid Acid Black 207 acetylsuccinic acid, diethyl ester Acid Black 210 4-acetylsulfanilamide Acid Black 227 N-acetylsulfanilyl chloride Acid Black 234 Name Index: Ashford’s Dictionary of Industrial Chemicals Acid Blue 1 Acid Blue 1 Acid Blue 118 Acid Blue 3 Acid Blue 119 Acid Blue 7 Acid Blue 120 Acid Blue 9 Acid Blue 127 Acid Blue 15 Acid Blue 129 Acid Blue 20 Acid Blue 138 Acid Blue 22 Acid Blue 145 Acid Blue 23 Acid Blue 158 Acid Blue 25 Acid Blue 158:1 Acid Blue 27 Acid Blue 161 Acid Blue 29 Acid Blue 171 Acid Blue 34 Acid Blue 185 Acid Blue 40 Acid Blue 193 Acid Blue 41 Acid Blue 193 Acid Blue 43 Acid Blue 213 Acid Blue 45 Acid Blue 225 Acid Blue 48 Acid Blue 230 Acid Blue 62 Acid Blue 249 Acid Blue 74 Acid Blue 260 Acid Blue 78 Acid Blue 277 Acid Blue 80 Acid Blue 279 Acid Blue 83 Acid Blue 296 Acid Blue 90 Acid Blue 314 Acid Blue 92 Acid Blue 324 Acid Blue 93 Acid Brown 2 Acid Blue 104 Acid Brown 4 Acid Blue 113 Acid Brown 13 Acid Blue 116 Acid Brown 14 Acid Blue 117 Acid Brown 50 Name Index: Ashford’s Dictionary of Industrial Chemicals Acid Brown 58 Acid Brown 58 Acid Green 20 Acid Brown 75 Acid Green 25 Acid Brown 83 Acid Green 27 Acid Brown 85 Acid Green 28 Acid Brown 98 Acid Green 40 Acid Brown 105 Acid Green 40:1 Acid Brown 106 Acid Green 41 Acid Brown 123 Acid Green 50 Acid Brown 126 Acid Green 68:1 Acid Brown 188 Acid Green 73 Acid Brown 216 Acid Green 84 Acid Brown 227 Acid Green 111 Acid Brown 237 Acid Orange 3 Acid Brown 248 Acid Orange 5 Acid Brown 289 Acid Orange 6 Acid Brown 290 Acid Orange 7 Acid Brown 298 Acid Orange 8 Acid Brown 348 Acid Orange 10 Acid Brown 349 Acid Orange 11 Acid Brown 365 Acid Orange 12 Acid Brown 402 Acid Orange 14 Acid Brown 436 Acid Orange 17 Acid Green 1 Acid Orange 19 Acid Green 3 Acid Orange 20 Acid Green 5 Acid Orange 24 Acid Green 9 Acid Orange 33 Acid Green 12 Acid Orange 51 Acid Green 16 Acid Orange 52 Acid Green 19 Acid Orange 56 Name Index: Ashford’s Dictionary of Industrial Chemicals Acid Orange 60 Acid Orange 60 Acid Red 52 Acid Orange 61 Acid Red 57 Acid Orange 67 Acid Red 66 Acid Orange 74 Acid Red 73 Acid Orange 80 Acid Red 82 Acid Orange 86 Acid Red 87 Acid Orange 94 Acid Red 88 Acid Orange 95 Acid Red 92 Acid Orange 116 Acid Red 94 Acid Orange 137 Acid Red 95 Acid Orange 152 Acid Red 97 Acid Orange 154 Acid Red 106 Acid Orange 156 Acid Red 111 Acid Orange 162 Acid Red 118 Acid Orange 165 Acid Red 119 Acid Red 1 Acid Red 131 Acid Red 4 Acid Red 134 Acid Red 6 Acid Red 137 Acid Red 13 Acid Red 138 Acid Red 14 Acid Red 145 Acid Red 17 Acid Red 151 Acid Red 18 Acid Red 154 Acid Red 27 Acid Red 163 Acid Red 33 Acid Red 179 Acid Red 35 Acid Red 182 Acid Red 37 Acid Red 183 Acid Red 42 Acid Red 184 Acid Red 44 Acid Red 186 Acid Red 51 Acid Red 195 Name Index: Ashford’s Dictionary of Industrial Chemicals Acid Red 211 Acid Red 211 Acid Violet 58 Acid Red 213 Acid Violet 62 Acid Red 226 Acid Violet
Recommended publications
  • Common and Chemical Names of Herbicides Approved by the WSSA

    Common and Chemical Names of Herbicides Approved by the WSSA

    Weed Science 2010 58:511–518 Common and Chemical Names of Herbicides Approved by the Weed Science Society of America Below is the complete list of all common and chemical of herbicides as approved by the International Organization names of herbicides approved by the Weed Science Society of for Standardization (ISO). A sponsor may submit a proposal America (WSSA) and updated as of September 1, 2010. for a common name directly to the WSSA Terminology Beginning in 1996, it has been published yearly in the last Committee. issue of Weed Science with Directions for Contributors to A herbicide common name is not synonymous with Weed Science. This list is published in lieu of the selections a commercial formulation of the same herbicide, and in printed previously on the back cover of Weed Science. Only many instances, is not synonymous with the active ingredient common and chemical names included in this complete of a commercial formulation as identified on the product list should be used in WSSA publications. In the absence of label. If the herbicide is a salt or simple ester of a parent a WSSA-approved common name, the industry code number compound, the WSSA common name applies to the parent as compiled by the Chemical Abstracts Service (CAS) with compound only. CAS systematic chemical name or the systematic chemical The chemical name used in this list is that preferred by the name alone may be used. The current approved list is also Chemical Abstracts Service (CAS) according to their system of available at our web site (www.wssa.net).
  • Glufosinate-Tolerant Cotton: Tolerance and Weed

    Glufosinate-Tolerant Cotton: Tolerance and Weed

    GLUFOSINATE-TOLERANT COTTON: TOLERANCE AND WEED MANAGEMENT by LESLI KRISTEN BLAIR, B.S. A THESIS IN CROP SCIENCE Submitted to the Graduate Faculty of Texas Tech University in Partial Fulfillment of the Requirements for the Degree of MASTER OF SCIENCE Approved Accepted Deamof the Graduate School December, 1991 ^^•ft:;^ ACKNOWLEDGEMENTS 1i would like to extend my heartfelt gratitude to the members that served on 7 '^ '^* my advisory committee for their time, effort, and assistance. I would like to thank Dr. Dotray for his guidance and direction in the preparation of this thesis; Dr. Keeling for his instruction and support in monitoring these experiments; Dr. Gannaway for his knowledge and assistance in the biotechnology and breeding associated with this project; and Dr. Thompson for her friendship and support in making career decisions. Without all of their guidance, I could never have achieved the goals that we set. I wish to thank all of my fellow graduate students in Weed Science for their help in completing this project. I would especially like to thank Alan Helm for his endless help collecting all of the first year data, Ginger Light for her help in clarifying concepts, and LeAnna Lyon for her help with the last year's project. Their support, friendship, and help on this project have been immeasurable. I would like to express my sincerest thanks to AgrEvo and TxCot for their funding of this research. My thanks also go to the people at the USDA-ARS in Lubbock for all of their help before and after I became involved with this research.
  • Daily Lifestyle Modifications to Improve Quality of Life And

    Daily Lifestyle Modifications to Improve Quality of Life And

    brain sciences Review Daily Lifestyle Modifications to Improve Quality of Life and Survival in Glioblastoma: A Review Sarah Travers and N. Scott Litofsky * Division of Neurosurgery, University of Missouri School of Medicine, Columbia, MO 65212, USA; [email protected] * Correspondence: [email protected] Abstract: Survival in glioblastoma remains poor despite advancements in standard-of-care treatment. Some patients wish to take a more active role in their cancer treatment by adopting daily lifestyle changes to improve their quality of life or overall survival. We review the available literature through PubMed and Google Scholar to identify laboratory animal studies, human studies, and ongoing clinical trials. We discuss which health habits patients adopt and which have the most promise in glioblastoma. While results of clinical trials available on these topics are limited, dietary restrictions, exercise, use of supplements and cannabis, and smoking cessation all show some benefit in the comprehensive treatment of glioblastoma. Marital status also has an impact on survival. Further clinical trials combining standard treatments with lifestyle modifications are necessary to quantify their survival advantages. Keywords: survival in glioblastoma; dietary restriction in glioblastoma; cannabis use in glioblastoma; supplementation in glioblastoma; glioblastoma health modifications Citation: Travers, S.; Litofsky, N.S. Daily Lifestyle Modifications to 1. Introduction Improve Quality of Life and Survival Glioblastoma remains the most aggressive and deadly form of primary brain tumor, in Glioblastoma: A Review. Brain Sci. with average survival rates ranging from 7.8 to 23.4 months after diagnosis [1]. Maximal 2021, 11, 533. https://doi.org/ surgical resection followed by radiation and temozolomide have become standard of 10.3390/brainsci11050533 care [2,3].
  • TRP Mediation

    TRP Mediation

    molecules Review Remedia Sternutatoria over the Centuries: TRP Mediation Lujain Aloum 1 , Eman Alefishat 1,2,3 , Janah Shaya 4 and Georg A. Petroianu 1,* 1 Department of Pharmacology, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates; [email protected] (L.A.); Eman.alefi[email protected] (E.A.) 2 Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates 3 Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, The University of Jordan, Amman 11941, Jordan 4 Pre-Medicine Bridge Program, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates; [email protected] * Correspondence: [email protected]; Tel.: +971-50-413-4525 Abstract: Sneezing (sternutatio) is a poorly understood polysynaptic physiologic reflex phenomenon. Sneezing has exerted a strange fascination on humans throughout history, and induced sneezing was widely used by physicians for therapeutic purposes, on the assumption that sneezing eliminates noxious factors from the body, mainly from the head. The present contribution examines the various mixtures used for inducing sneezes (remedia sternutatoria) over the centuries. The majority of the constituents of the sneeze-inducing remedies are modulators of transient receptor potential (TRP) channels. The TRP channel superfamily consists of large heterogeneous groups of channels that play numerous physiological roles such as thermosensation, chemosensation, osmosensation and mechanosensation. Sneezing is associated with the activation of the wasabi receptor, (TRPA1), typical ligand is allyl isothiocyanate and the hot chili pepper receptor, (TRPV1), typical agonist is capsaicin, in the vagal sensory nerve terminals, activated by noxious stimulants.
  • (CD-P-PH/PHO) Report Classification/Justifica

    (CD-P-PH/PHO) Report Classification/Justifica

    COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) Report classification/justification of medicines belonging to the ATC group D07A (Corticosteroids, Plain) Table of Contents Page INTRODUCTION 4 DISCLAIMER 6 GLOSSARY OF TERMS USED IN THIS DOCUMENT 7 ACTIVE SUBSTANCES Methylprednisolone (ATC: D07AA01) 8 Hydrocortisone (ATC: D07AA02) 9 Prednisolone (ATC: D07AA03) 11 Clobetasone (ATC: D07AB01) 13 Hydrocortisone butyrate (ATC: D07AB02) 16 Flumetasone (ATC: D07AB03) 18 Fluocortin (ATC: D07AB04) 21 Fluperolone (ATC: D07AB05) 22 Fluorometholone (ATC: D07AB06) 23 Fluprednidene (ATC: D07AB07) 24 Desonide (ATC: D07AB08) 25 Triamcinolone (ATC: D07AB09) 27 Alclometasone (ATC: D07AB10) 29 Hydrocortisone buteprate (ATC: D07AB11) 31 Dexamethasone (ATC: D07AB19) 32 Clocortolone (ATC: D07AB21) 34 Combinations of Corticosteroids (ATC: D07AB30) 35 Betamethasone (ATC: D07AC01) 36 Fluclorolone (ATC: D07AC02) 39 Desoximetasone (ATC: D07AC03) 40 Fluocinolone Acetonide (ATC: D07AC04) 43 Fluocortolone (ATC: D07AC05) 46 2 Diflucortolone (ATC: D07AC06) 47 Fludroxycortide (ATC: D07AC07) 50 Fluocinonide (ATC: D07AC08) 51 Budesonide (ATC: D07AC09) 54 Diflorasone (ATC: D07AC10) 55 Amcinonide (ATC: D07AC11) 56 Halometasone (ATC: D07AC12) 57 Mometasone (ATC: D07AC13) 58 Methylprednisolone Aceponate (ATC: D07AC14) 62 Beclometasone (ATC: D07AC15) 65 Hydrocortisone Aceponate (ATC: D07AC16) 68 Fluticasone (ATC: D07AC17) 69 Prednicarbate (ATC: D07AC18) 73 Difluprednate (ATC: D07AC19) 76 Ulobetasol (ATC: D07AC21) 77 Clobetasol (ATC: D07AD01) 78 Halcinonide (ATC: D07AD02) 81 LIST OF AUTHORS 82 3 INTRODUCTION The availability of medicines with or without a medical prescription has implications on patient safety, accessibility of medicines to patients and responsible management of healthcare expenditure. The decision on prescription status and related supply conditions is a core competency of national health authorities.
  • ECO-Ssls for Pahs

    ECO-Ssls for Pahs

    Ecological Soil Screening Levels for Polycyclic Aromatic Hydrocarbons (PAHs) Interim Final OSWER Directive 9285.7-78 U.S. Environmental Protection Agency Office of Solid Waste and Emergency Response 1200 Pennsylvania Avenue, N.W. Washington, DC 20460 June 2007 This page intentionally left blank TABLE OF CONTENTS 1.0 INTRODUCTION .......................................................1 2.0 SUMMARY OF ECO-SSLs FOR PAHs......................................1 3.0 ECO-SSL FOR TERRESTRIAL PLANTS....................................4 5.0 ECO-SSL FOR AVIAN WILDLIFE.........................................8 6.0 ECO-SSL FOR MAMMALIAN WILDLIFE..................................8 6.1 Mammalian TRV ...................................................8 6.2 Estimation of Dose and Calculation of the Eco-SSL ........................9 7.0 REFERENCES .........................................................16 7.1 General PAH References ............................................16 7.2 References Used for Derivation of Plant and Soil Invertebrate Eco-SSLs ......17 7.3 References Rejected for Use in Derivation of Plant and Soil Invertebrate Eco-SSLs ...............................................................18 7.4 References Used in Derivation of Wildlife TRVs .........................25 7.5 References Rejected for Use in Derivation of Wildlife TRV ................28 i LIST OF TABLES Table 2.1 PAH Eco-SSLs (mg/kg dry weight in soil) ..............................4 Table 3.1 Plant Toxicity Data - PAHs ..........................................5 Table 4.1
  • Targeting Angiogenesis by Phytochemicals

    Targeting Angiogenesis by Phytochemicals

    Arom & at al ic in P l ic a n d t Kadioglu et al., Med Aromat Plants 2013, 2:5 e s M Medicinal & Aromatic Plants DOI: 10.4172/2167-0412.1000134 ISSN: 2167-0412 ResearchReview Article Article OpenOpen Access Access Targeting Angiogenesis By Phytochemicals Onat Kadioglu, Ean Jeong Seo and Thomas Efferth* Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany Abstract Cancer is a major cause of death worldwide and angiogenesis is critical in cancer progression. Development of new blood vessels and nutrition of tumor cells are heavily dependent on angiogenesis. Thus, angiogenesis inhibition might be a promising approach for anticancer therapy. Anti-angiogenic small molecule and phytochemicals as a cancer treatment approach are focused in these main points; modes of action, adverse effects, mechanisms of resistance and new developments. Treatment with anti-angiogenic compounds might be advantageous over conventional chemotherapy due to the fact that those compounds mainly act on endothelial cells, which are genetically more stable and homogenous compared to tumor cells and they show lower susceptibility to acquired drug resistance (ADR). Targeting the VEGF (vascular endothelial growth factor) signalling pathway with synthetic small molecules inhibiting Receptor Tyrosine Kinases (RTKs) in addition to antagonizing VEGF might be a promising approach. Moreover, beneficial effect of phytochemicals were proven on cancer-related pathways especially concerning anti-angiogenesis. Plant phenolics being an important category of prominent phytochemicals affect different pathways of angiogenesis. Green tea polyphenols (epigallocatechin gallate) and soy bean isoflavones (genistein) are two examples involving an anti-angiogenic effect.
  • Muscarinic Acetylcholine Receptor

    Muscarinic Acetylcholine Receptor

    mAChR Muscarinic acetylcholine receptor mAChRs (muscarinic acetylcholine receptors) are acetylcholine receptors that form G protein-receptor complexes in the cell membranes of certainneurons and other cells. They play several roles, including acting as the main end-receptor stimulated by acetylcholine released from postganglionic fibersin the parasympathetic nervous system. mAChRs are named as such because they are more sensitive to muscarine than to nicotine. Their counterparts are nicotinic acetylcholine receptors (nAChRs), receptor ion channels that are also important in the autonomic nervous system. Many drugs and other substances (for example pilocarpineand scopolamine) manipulate these two distinct receptors by acting as selective agonists or antagonists. Acetylcholine (ACh) is a neurotransmitter found extensively in the brain and the autonomic ganglia. www.MedChemExpress.com 1 mAChR Inhibitors & Modulators (+)-Cevimeline hydrochloride hemihydrate (-)-Cevimeline hydrochloride hemihydrate Cat. No.: HY-76772A Cat. No.: HY-76772B Bioactivity: Cevimeline hydrochloride hemihydrate, a novel muscarinic Bioactivity: Cevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome. IC50 value: Target: mAChR xerostomia in Sjogren's syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other… gastrointestinal, urinary, and reproductive systems and other… Purity: >98% Purity: >98% Clinical Data: No Development Reported Clinical Data: No Development Reported Size: 10mM x 1mL in DMSO, Size: 10mM x 1mL in DMSO, 1 mg, 5 mg 1 mg, 5 mg AC260584 Aclidinium Bromide Cat. No.: HY-100336 (LAS 34273; LAS-W 330) Cat.
  • WO 2013/037955 Al 21 March 2013 (21.03.2013) P O P C T

    WO 2013/037955 Al 21 March 2013 (21.03.2013) P O P C T

    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2013/037955 Al 21 March 2013 (21.03.2013) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A01N 25/00 (2006.01) A OIN 43/653 (2006.01) kind of national protection available): AE, AG, AL, AM, A0 41/06 (2006.01) A01N 37/50 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (21) Number: International Application DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/EP2012/068096 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 14 September 2012 (14.09.2012) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, (25) Filing Language: English RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, (26) Publication Language: English TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 1118 1702.9 16 September 201 1 (16.09.201 1) EP (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant (for all designated States except US): BAYER GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, INTELLECTUAL PROPERTY GMBH [DE/DE]; Al- UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, fred-Nobel-Str.
  • Classification of Medicinal Drugs and Driving: Co-Ordination and Synthesis Report

    Classification of Medicinal Drugs and Driving: Co-Ordination and Synthesis Report

    Project No. TREN-05-FP6TR-S07.61320-518404-DRUID DRUID Driving under the Influence of Drugs, Alcohol and Medicines Integrated Project 1.6. Sustainable Development, Global Change and Ecosystem 1.6.2: Sustainable Surface Transport 6th Framework Programme Deliverable 4.4.1 Classification of medicinal drugs and driving: Co-ordination and synthesis report. Due date of deliverable: 21.07.2011 Actual submission date: 21.07.2011 Revision date: 21.07.2011 Start date of project: 15.10.2006 Duration: 48 months Organisation name of lead contractor for this deliverable: UVA Revision 0.0 Project co-funded by the European Commission within the Sixth Framework Programme (2002-2006) Dissemination Level PU Public PP Restricted to other programme participants (including the Commission x Services) RE Restricted to a group specified by the consortium (including the Commission Services) CO Confidential, only for members of the consortium (including the Commission Services) DRUID 6th Framework Programme Deliverable D.4.4.1 Classification of medicinal drugs and driving: Co-ordination and synthesis report. Page 1 of 243 Classification of medicinal drugs and driving: Co-ordination and synthesis report. Authors Trinidad Gómez-Talegón, Inmaculada Fierro, M. Carmen Del Río, F. Javier Álvarez (UVa, University of Valladolid, Spain) Partners - Silvia Ravera, Susana Monteiro, Han de Gier (RUGPha, University of Groningen, the Netherlands) - Gertrude Van der Linden, Sara-Ann Legrand, Kristof Pil, Alain Verstraete (UGent, Ghent University, Belgium) - Michel Mallaret, Charles Mercier-Guyon, Isabelle Mercier-Guyon (UGren, University of Grenoble, Centre Regional de Pharmacovigilance, France) - Katerina Touliou (CERT-HIT, Centre for Research and Technology Hellas, Greece) - Michael Hei βing (BASt, Bundesanstalt für Straßenwesen, Germany).
  • OECD Environment Health and Safety Publications Series on Testing and Assessment No

    OECD Environment Health and Safety Publications Series on Testing and Assessment No

    OECD Environment Health and Safety Publications Series on Testing and Assessment No. 21 Detailed Review Paper Appraisal of Test Methods for Sex Hormone Disrupting Chemicals Environment Directorate ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT Paris May 2001 1 Also Published in the Series Testing and Assessment: No. 1, Guidance Document for the Development of OECD Guidelines for Testing of Chemicals (1993; reformatted 1995) No. 2, Detailed Review Paper on Biodegradability Testing (1995) No. 3, Guidance Document for Aquatic Effects Assessment (1995) No. 4, Report of the OECD Workshop on Environmental Hazard/Risk Assessment (1995) No. 5, Report of the SETAC/OECD Workshop on Avian Toxicity Testing (1996) No. 6, Report of the Final Ring-test of the Daphnia magna Reproduction Test (1997) No. 7, Guidance Document on Direct Phototransformation of Chemicals in Water (1997) No. 8, Report of the OECD Workshop on Sharing Information about New Industrial Chemicals Assessment (1997) No. 9 Guidance Document for the Conduct of Studies of Occupational Exposure to Pesticides During Agricultural Application (1997) No. 10, Report of the OECD Workshop on Statistical Analysis of Aquatic Toxicity Data (1998) No. 11, Detailed Review Paper on Aquatic Testing Methods for Pesticides and industrial Chemicals (1998) No. 12, Detailed Review Document on Classification Systems for Germ Cell Mutagenicity in OECD Member Countries (1998) No. 13, Detailed Review Document on Classification Systems for Sensitising Substances in OECD Member Countries 1998) No. 14, Detailed Review Document on Classification Systems for Eye Irritation/Corrosion in OECD Member Countries (1998) No. 15, Detailed Review Document on Classification Systems for Reproductive Toxicity in OECD Member Countries (1998) No.
  • Acne Vulgaris and Intake of Selected Dietary Nutrients—A Summary of Information

    Acne Vulgaris and Intake of Selected Dietary Nutrients—A Summary of Information

    healthcare Review Acne Vulgaris and Intake of Selected Dietary Nutrients—A Summary of Information Aleksandra Podgórska †, Anna Pu´scion-Jakubik*,† , Renata Markiewicz-Zukowska˙ , Krystyna Joanna Gromkowska-K˛epkaand Katarzyna Socha Department of Bromatology, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Białystok, Mickiewicza 2D Street, 15-222 Białystok, Poland; [email protected] (A.P.); [email protected] (R.M.-Z.);˙ [email protected] (K.J.G.-K.); [email protected] (K.S.) * Correspondence: [email protected]; Tel.: +48-8574-854-69 † Contributed equally. Abstract: Acne vulgaris (AV) is a chronic disease that affects a significant percentage of the world’s population. Its development is influenced by both external and internal factors. The purpose of this review is to demonstrate the effect of basic nutrient intake on the exacerbation or alleviation of AV lesions. A retrospective review of publications in PubMed regarding diet therapy and the impact of individual nutrient intake on the skin condition of patients was conducted. Ingestion of products with a high glycaemic index may indirectly lead to sebum overproduction, which promotes infection with Cutibacterium acnes and causes inflammation. Consumption of certain dairy products may result Citation: Podgórska, A.; in skin deterioration caused by the presence of hormones in these products, i.e., progesterone and Pu´scion-Jakubik,A.; testosterone precursors. The beneficial effect of fatty acids on the skin is manifested by the reduction Markiewicz-Zukowska,˙ R.; Gromkowska-K˛epka,K.J.; Socha, K. in inflammation. Of significance in AV treatment are vitamins A, C, D, E and B, as well as mineral Acne Vulgaris and Intake of Selected elements zinc and selenium.